Evidence-based reasons for segregation of patients colonized with Pseudomon
as aerugionsa in the outpatient setting are unclear. To clarify local decis
ions, Pseudomonas genotyping of the local environment, patients and patient
contacts was undertaken in 1993. The hospital environment was re-swabbed i
n 1997. Pseudomonas genotyping of old and new patients attending the North
Staffordshire cystic fibrosis clinic has subsequently been undertaken and m
ore recently been repeated on an annual basis to assess whether the same Ps
eudomonas genotypes can be found in both the environment and in patients, a
nd whether the same Pseudomonas genotype can be transferred from one patien
t to another.
No Pseudomonas genotype found in the local environment in 1993 or in 1997 h
as been found in any of our patients. Nine children attending the. same spe
cial school for many years and sharing the same physiotherapy facilities sh
owed no evidence of cross-infectivity. Except for siblings living in the sa
me household our cross-infectivity rate is very low and where cross-infecti
on has potentially occurred the level of contact between these patients has
been minimal. This study does not support the suggestion that patients wit
h cystic fibrosis attending the North Staffordshire clinic and colonized wi
th Pseudomonas aeruginosa should be segregated from non-colonized patients.